United Kingdom· GB-APID-19660711000001104
Remifentanil 1mg powder for concentrate for solution for injection vials
A remifentanil product containing remifentanil, registered in United Kingdom by Wockhardt UK Ltd. The same ATC class is registered in 18 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Remifentanil is registered in 18 of 19 countries.
Countries holding a registration under ATC N01AH06 (remifentanil), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Remifentanil · ATC N01AH06
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of remifentanil costs, country by country.
Normalised to the WHO defined daily dose (52.5 mcg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Remifentanil · price per daily dose (52.5 mcg)
USD · FX 28 Sept 2026
- FI Finland$0.30
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Remifentanil
- Manufacturer
- Wockhardt UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- N01AH06
- ATC class
- Remifentanil
- Defined daily dose
- 52.5 mcg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5012727906744
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
123 interactions on record for remifentanil.
Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Remifentanil · interactions on record
123 records
- 18 severe
- 91 moderate
- 14 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Remifentanil in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandRemifentanil ActavisActavis Group PTC ehf
- BelgiumRemifentanil Actavis 1 mgActavis Group PTC
- SpainREMIFENTANILO ACCORD 1 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE O PERFUSION EFGAccord Healthcare S.L.U.
- United StatesRemifentanil HydrochlorideFresenius Kabi USA, LLC
- SwedenRemifentanil B. Braun 1 mg Pulver till koncentrat till injektions-/infusionsvätska, lösningB. Braun Melsungen AG
- NetherlandsRemifentanil Aurobindo 1 mg, poeder voor concentraat voor oplossing voor infusie/injectieAurobindo Pharma B.V.
- IrelandRemifentanil 1 mg powder for concentrate for solution for injection or infusionFresenius Kabi Deutschland GmbH
- SwitzerlandRemifentanil Fresenius 1 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungFresenius Kabi (Schweiz) AG
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Remifentanil Hameln, Remifentanil Kabi
- Belgium · Ultiva
- Bulgaria · Ремифентанил Хамелн, Ремифентанил-Чайкафарма
- Cyprus · Refenta
- Czechia · Remifentanil B. Braun
- Germany · Remifentanil B. Braun, Remifentanil Genmed
- Denmark · Remifentanil B. Braun, Remifentanil Fresenius Kabi
- Estonia · Remifentanil Kabi
- Spain · Remifentanilo Kern Pharma, Remifentanilo Noridem
- Finland · Remifentanil, Remifentanil B. Braun
- France · Remifentanil Piramal, Remifentanil Viatris
- Greece · Dormiden, Remifentanil Anfarm
- Croatia · Remifentanil Hameln
- Ireland · Remifentanil, Remifentanil Fresenius Kabi Deutschland
- Iceland · Remifentanil Hameln
- Italy · Remifentanil Hameln, Remifentanil Mylan Generics
- Lithuania · Remifentanil Kabi
- Luxembourg · Ultiva
- Latvia · Remifentanil Kabi
- Malta · Remifentanil Anfarm, Remifentanil Noridem
- Netherlands · Remifentanil B. Braun, Remifentanil Fresenius Kabi
- Norway · Remifentanil Hameln, Remifentanil Orion
- Poland · Ultiva
- Portugal · Remifentanilo Accord, Remifentanilo Asklepius
- Romania · Remifentanil Kabi
- Sweden · Remifentanil B. Braun, Remifentanil Hameln
- Slovenia · Remifentanil Hameln
- Slovakia · Remifentanil B. Braun, Ultiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d6459b0a-624e-411b-9325-973d26a696ed GET /v1/drugs/d6459b0a-624e-411b-9325-973d26a696ed?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "19660711000001104",
"desc": "Remifentanil 1mg powder for concentrate for solution for injection vials (Wockhardt UK Ltd)",
"form": "Powder for solution for injection",
"vpid": "42017011000001100",
"source": "dmd",
"vtm_id": "777417003",
"strength": "1 mg",
"substance": "Remifentanil",
"ingredient": "Remifentanyl hydrochloride",
"supplier_code": "9301611000001105"
}See everything about remifentanil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.